3251 - 3300 of 8620 Results
Title
Year
-
RESTRICTEDTitle: Symptomatic Care in Multiple System Atrophy: State of the ArtJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 22Issue #: 3Start Page: 433End Page: 446Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-022-01411-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-022-01411-6.pdfCitation Count: 7
-
RESTRICTEDTitle: Digital Technology in Movement Disorders: Updates, Applications, and ChallengesJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 21Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-021-01101-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11910-021-01101-6.pdfCitation Count: 30
- Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson’s Disease2020RESTRICTEDTitle: Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson’s DiseaseJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 34Issue #: 6Start Page: 559End Page: 577Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-020-00727-3Citation Count: 6
-
RESTRICTEDTitle: 24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical RecommendationsJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 2Start Page: 137End Page: 149Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-020-00782-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-020-00782-w.pdfCitation Count: 17
-
RESTRICTEDTitle: Targeting β-Arrestins in the Treatment of Psychiatric and Neurological DisordersJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 3Start Page: 253End Page: 264Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-021-00796-yCitation Count: 8
- Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis2022RESTRICTEDTitle: Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysisJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 12Start Page: 1269End Page: 1283Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-022-00963-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-022-00963-9.pdfCitation Count: 14
-
RESTRICTEDTitle: Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s DiseaseJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 12Start Page: 1249End Page: 1267Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-022-00973-7Citation Count: 5
- The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and Suitability2021RESTRICTEDTitle: The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and SuitabilityJournal Name: Drugs & AgingPublisher: Springer Science and Business Media LLCVol: 38Issue #: 5Start Page: 355End Page: 373Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40266-021-00853-7Best OA location URL: https://discovery.ucl.ac.uk/10124963/5/Foltynie_Incretin-based_Therapies_Review_CG_24.02.21CA.pdfCitation Count: 6
-
RESTRICTEDTitle: Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's DiseaseJournal Name: DrugsPublisher: Springer Science and Business Media LLCVol: 82Issue #: 10Start Page: 1027End Page: 1053Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40265-022-01747-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40265-022-01747-7.pdfCitation Count: 9
- Neutrophil activation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid2020RESTRICTEDTitle: Neutrophil activation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluidJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 62Issue #:Start Page: 101130End Page: 101130Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2020.101130Citation Count: 26
-
RESTRICTEDTitle: What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?Journal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 79Issue #:Start Page: 101648End Page: 101648Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.arr.2022.101648Best OA location URL: https://doi.org/10.1016/j.arr.2022.101648Citation Count: 11
- Environmental neurotoxicants and inflammasome activation in Parkinson’s disease – A focus on the gut-brain axis2022RESTRICTEDTitle: Environmental neurotoxicants and inflammasome activation in Parkinson’s disease – A focus on the gut-brain axisJournal Name: The International Journal of Biochemistry & Cell BiologyPublisher: Elsevier BVVol: 142Issue #:Start Page: 106113End Page: 106113Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biocel.2021.106113Citation Count: 8
-
RESTRICTEDTitle: Mechanisms of NLRP3 activation and pathology during neurodegenerationJournal Name: The International Journal of Biochemistry & Cell BiologyPublisher: Elsevier BVVol: 151Issue #:Start Page: 106273End Page: 106273Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biocel.2022.106273Citation Count: 10
- Strategies for quantifying the enzymatic activities of glycoside hydrolases within cells and in vivo2023RESTRICTEDTitle: Strategies for quantifying the enzymatic activities of glycoside hydrolases within cells and in vivoJournal Name: Current Opinion in Chemical BiologyPublisher: Elsevier BVVol: 77Issue #:Start Page: 102403End Page: 102403Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cbpa.2023.102403Citation Count: 0
-
RESTRICTEDTitle: Adapting the proteostasis capacity to sustain brain healthspanJournal Name: CellPublisher: Elsevier BVVol: 184Issue #: 6Start Page: 1545End Page: 1560Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cell.2021.02.007Best OA location URL: http://www.cell.com/article/S0092867421001574/pdfCitation Count: 66
-
RESTRICTEDTitle: Orthostatic Hypotension in Parkinson DiseaseJournal Name: Clinics in Geriatric MedicinePublisher: Elsevier BVVol: 36Issue #: 1Start Page: 53End Page: 67Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cger.2019.09.002Best OA location URL: https://europepmc.org/articles/pmc7029426?pdf=renderCitation Count: 48
-
RESTRICTEDTitle: Human brain connectivity: Clinical applications for clinical neurophysiologyJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 131Issue #: 7Start Page: 1621End Page: 1651Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2020.03.031Citation Count: 70
- Pharmacokinetic profile of the selective 5-HT3 receptor antagonist ondansetron in the rat: an original study and a minireview of the behavioural pharmacological literature in the rat2020RESTRICTEDTitle: Pharmacokinetic profile of the selective 5-HT3 receptor antagonist ondansetron in the rat: an original study and a minireview of the behavioural pharmacological literature in the ratJournal Name: Canadian Journal of Physiology and PharmacologyPublisher: Canadian Science PublishingVol: 98Issue #: 7Start Page: 431End Page: 440Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1139/cjpp-2019-0551Citation Count: 7
-
OPENTitle: Recent Advances on Graph Analytics and Its Applications in HealthcareJournal Name: Proceedings of the 26th ACM SIGKDD International Conference on Knowledge Discovery & Data MiningPublisher: ACMVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1145/3394486.3406469Best OA location URL: https://dl.acm.org/doi/pdf/10.1145/3394486.3406469Citation Count: 9
-
RESTRICTEDTitle: Initiation of pharmacological therapy in Parkinson's disease: when, why, and howJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 5Start Page: 452End Page: 461Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30036-3Citation Count: 121
- Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias2020RESTRICTEDTitle: Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 951End Page: 962Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/s1474-4422(20)30314-8Best OA location URL: http://manuscript.elsevier.com/S1474442220303148/pdf/S1474442220303148.pdfCitation Count: 283
-
RESTRICTEDTitle: Progress towards therapies for disease modification in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 7Start Page: 559End Page: 572Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00061-2Best OA location URL: https://discovery.ucl.ac.uk/10130306/1/Foltynie_Disease%20Modifying%20reviewVersion4_ML2_CLEAN.pdfCitation Count: 157
-
RESTRICTEDTitle: A biological classification of Huntington's disease: the Integrated Staging SystemJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 7Start Page: 632End Page: 644Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00120-xBest OA location URL: https://discovery.ucl.ac.uk/10151755/1/21.08.12%20HD-ISS%20Manuscript%20final%20submitted.pdfCitation Count: 86
-
RESTRICTEDTitle: Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatmentJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 124End Page: 132Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.027Best OA location URL: http://www.prd-journal.com/article/S1353802021001206/pdfCitation Count: 25
- Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson's disease: Results from a pooled meta-analysis2021RESTRICTEDTitle: Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson's disease: Results from a pooled meta-analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 52End Page: 57Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.009Best OA location URL: http://www.prd-journal.com/article/S1353802021001024/pdfCitation Count: 2
- Should we start integrating genetic data in decision-making on device-aided therapies in Parkinson disease? A point of view2021RESTRICTEDTitle: Should we start integrating genetic data in decision-making on device-aided therapies in Parkinson disease? A point of viewJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 88Issue #:Start Page: 51End Page: 57Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.05.013Citation Count: 16
- Presynaptic Hemiparkinsonism Following Cerebral Toxoplasmosis: Case Report and Literature Review2022RESTRICTEDTitle: Presynaptic Hemiparkinsonism Following Cerebral Toxoplasmosis: Case Report and Literature ReviewJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 2Start Page: 285End Page: 299Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13631Citation Count: 2
- Transitional Care for Young People with Neurological Disorders: A Scoping Review with A Focus on Patients with Movement Disorders2020RESTRICTEDTitle: Transitional Care for Young People with Neurological Disorders: A Scoping Review with A Focus on Patients with Movement DisordersJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1316End Page: 1324Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28381Citation Count: 9
-
RESTRICTEDTitle: Anti‐IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the LiteratureJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 1Start Page: 115End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13614Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13614Citation Count: 6
-
RESTRICTEDTitle: Neuroimaging of Anxiety in Parkinson's Disease: A Systematic ReviewJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 2Start Page: 327End Page: 339Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28404Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28404Citation Count: 80
- Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice2020RESTRICTEDTitle: Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practiceJournal Name: CNS SpectrumsPublisher: Cambridge University Press (CUP)Vol: 27Issue #: 2Start Page: 208End Page: 217Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1017/s109285292000200xCitation Count: 25
-
RESTRICTEDTitle: LRRK2-targeted Parkinson disease drug advances into phase IIIJournal Name: Nature Reviews Drug DiscoveryPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page: 3End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/d41573-022-00212-0Citation Count: 8
-
RESTRICTEDTitle: Signaling cascades in the failing heart and emerging therapeutic strategiesJournal Name: Signal Transduction and Targeted TherapyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41392-022-00972-6Best OA location URL: https://www.nature.com/articles/s41392-022-00972-6.pdfCitation Count: 21
- An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics2021RESTRICTEDTitle: An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnosticsJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01201-xBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-021-01201-xCitation Count: 87
- Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis2020RESTRICTEDTitle: Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysisJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 4Start Page: 426End Page: 433Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2019-322169Best OA location URL: https://scholarlypublications.universiteitleiden.nl/access/item%3A3627324/viewCitation Count: 50
-
RESTRICTEDTitle: Parkinson’s disease: etiopathogenesis and treatmentJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 8Start Page: 795End Page: 808Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2019-322338Best OA location URL: https://jnnp.bmj.com/content/jnnp/91/8/795.full.pdfCitation Count: 478
- Quality of life outcomes after globus pallidus internus deep brain stimulation in idiopathic or inherited isolated dystonia: a meta-analysis2020RESTRICTEDTitle: Quality of life outcomes after globus pallidus internus deep brain stimulation in idiopathic or inherited isolated dystonia: a meta-analysisJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 9Start Page: 938End Page: 944Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2019-322575Citation Count: 10
-
RESTRICTEDTitle: Clinical trials in REM sleep behavioural disorder: challenges and opportunitiesJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 7Start Page: 740End Page: 749Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2020-322875Best OA location URL: https://jnnp.bmj.com/content/jnnp/91/7/740.full.pdfCitation Count: 55
-
RESTRICTEDTitle: Data-driven evolution of neurosurgical gene therapy delivery in Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 11Start Page: 1210End Page: 1218Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/jnnp-2020-322904Best OA location URL: https://jnnp.bmj.com/content/jnnp/91/11/1210.full.pdfCitation Count: 18
-
RESTRICTEDTitle: Parkinson's disease and skinJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 61End Page: 76Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.017Best OA location URL: http://www.prd-journal.com/article/S1353802020308671/pdfCitation Count: 28
- Towards subgroup-specific risk estimates: A meta-analysis of longitudinal studies on olfactory dysfunction and risk of Parkinson's disease2021RESTRICTEDTitle: Towards subgroup-specific risk estimates: A meta-analysis of longitudinal studies on olfactory dysfunction and risk of Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 155End Page: 163Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.005Best OA location URL: http://www.prd-journal.com/article/S1353802021000201/pdfCitation Count: 4
- Nitric Oxide-Dependent Protein Post-Translational Modifications Impair Mitochondrial Function and Metabolism to Contribute to Neurodegenerative Diseases2020RESTRICTEDTitle: Nitric Oxide-Dependent Protein Post-Translational Modifications Impair Mitochondrial Function and Metabolism to Contribute to Neurodegenerative DiseasesJournal Name: Antioxidants & Redox SignalingPublisher: Mary Ann Liebert IncVol: 32Issue #: 12Start Page: 817End Page: 833Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/ars.2019.7916Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074890Citation Count: 37
- Protein Transnitrosylation Signaling Networks Contribute to Inflammaging and Neurodegenerative Disorders2021RESTRICTEDTitle: Protein Transnitrosylation Signaling Networks Contribute to Inflammaging and Neurodegenerative DisordersJournal Name: Antioxidants & Redox SignalingPublisher: Mary Ann Liebert IncVol: 35Issue #: 7Start Page: 531End Page: 550Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/ars.2021.0081Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388249Citation Count: 22
- Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size and concentration2020RESTRICTEDTitle: Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size and concentrationJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1080/20013078.2020.1816641Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1080/20013078.2020.1816641Citation Count: 82
-
RESTRICTEDTitle: Delivery of RNA Therapeutics: The Great Endosomal Escape!Journal Name: Nucleic Acid TherapeuticsPublisher: Mary Ann Liebert IncVol: 32Issue #: 5Start Page: 361End Page: 368Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/nat.2022.0004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595607Citation Count: 44
-
RESTRICTEDTitle: Seeking progress in disease modification in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 134End Page: 141Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.006Citation Count: 10
- Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis2022RESTRICTEDTitle: Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 119End Page: 128Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.004Citation Count: 12
- The Role of Alpha-Synuclein and Other Parkinson’s Genes in Neurodevelopmental and Neurodegenerative Disorders2020RESTRICTEDTitle: The Role of Alpha-Synuclein and Other Parkinson’s Genes in Neurodevelopmental and Neurodegenerative DisordersJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 21Issue #: 16Start Page: 5724End Page: 5724Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms21165724Best OA location URL: https://www.mdpi.com/1422-0067/21/16/5724/pdf?version=1597054716Citation Count: 43
-
RESTRICTEDTitle: Establishing gene regulatory networks from Parkinson’s disease risk lociJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 7Start Page: 2422End Page: 2435Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac022Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awac022/42334003/awac022.pdfCitation Count: 12
-
OPENTitle: Chromatin Mechanics Dictates Subdiffusion and Coarsening Dynamics of Embedded CondensatesJournal Name: Biophysical JournalPublisher: Elsevier BVVol: 120Issue #: 3Start Page: 318aEnd Page: 318aPublication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bpj.2020.11.2012Best OA location URL: http://www.cell.com/article/S0006349520329192/pdfCitation Count: 13